The Next Steps in Cervical Screening | Zendy

Rengaswamy Sankaranarayanan | Zendy; YouLin Qiao | Zendy; Namory Keita | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Next Steps in Cervical Screening

Author(s) -

Rengaswamy Sankaranarayanan,

YouLin Qiao,

Namory Keita

Publication year - 2015

Publication title -

women s health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.363

H-Index - 39

eISSN - 1745-5065

pISSN - 1745-5057

DOI - 10.2217/whe.14.70

Subject(s) - medicine , cervical cancer , cervical cancer screening , hpv vaccines , gynecology , vaccination , human papillomavirus , disease , developing country , burden of disease , low and middle income countries , disease burden , cervical screening , family medicine , hpv infection , cancer , immunology , economic growth , economics

Cervical cancer is fourth most common cancer among women with four-fifths of the global burden in low- and middle-income countries (LMICs). Persistent infection with one of the high-risk types of human papillomaviruses (HPV), particularly HPV 16/18, is the central cause of cervical neoplasia. Progress in developing feasible, alternative screening methods in LMICs and HPV vaccines have further improved cervical cancer prevention prospects. While existing screening programs in high-income countries should be re-organized, in view of the downstream effects of national HPV vaccination programs, LMICs should introduce national programs to vaccinate single year cohorts of girls aged 9–13 years with two or three doses and screen 30–35-year-old women with HPV testing to pragmatically decrease their high disease burden.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research